id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-V-0331-0006,FDA,FDA-2021-V-0331,Variance Amendment from Osa International,Other,Amendment,2026-09-24T04:00:00Z,2026,9,2026-09-24T04:00:00Z,,2026-09-24T22:26:02Z,,0,0,09000064b9577309
FDA-2021-V-0331-0005,FDA,FDA-2021-V-0331,"Variance Approval Letter from FDA CDRH to OSA International, INC",Other,Approval for Variance (VRA),2026-09-15T04:00:00Z,2026,9,2026-09-15T04:00:00Z,,2026-09-15T17:57:18Z,,0,0,09000064b955bc37
FDA-2021-V-0331-0004,FDA,FDA-2021-V-0331,Variance Amendment from OSA International,Other,Amendment,2026-09-01T04:00:00Z,2026,9,2026-09-01T04:00:00Z,,2026-09-01T21:36:14Z,,0,0,09000064b94b8b1f
FDA-2021-V-0331-0003,FDA,FDA-2021-V-0331,Variance Approval Letter from FDA CDRH to OSA International Inc,Other,Approval for Variance (VRA),2021-05-06T04:00:00Z,2021,5,2021-05-06T04:00:00Z,,2021-05-06T13:39:48Z,,0,0,0900006484ad3cd0
FDA-2021-V-0331-0002,FDA,FDA-2021-V-0331,Acknowledgment Letter from FDA DMS to OSA International Inc.,Other,Acknowledgement Letter/Receipt,2021-04-02T04:00:00Z,2021,4,2021-04-02T04:00:00Z,,2021-04-02T15:22:09Z,,0,0,0900006484a8124a
FDA-2021-V-0331-0001,FDA,FDA-2021-V-0331,Variance Application from OSA International Inc,Other,Application for Variance (VAR),2021-04-02T04:00:00Z,2021,4,2021-04-02T04:00:00Z,,2021-04-02T15:16:06Z,,0,0,0900006484a81247